Therapeutic Area | Rare Disease Hub 2.0

This is a promotional website intended for UK healthcare professionals only, developed and funded by Takeda.
Details on how to report adverse events are found at the bottom of this page.

Inherited Metabolic Disorders

video

Two Decades of Experience from the Fabry Outcome Survey

Two Decades of Experience from the Fabry Outcome Survey demonstrating the long-term effectiveness of agalsidase alfa enzyme replacement therapy.

Inherited Metabolic Disorders

video

Two Decades of Experience from the Fabry Outcome Survey

Dr. Uma Ramaswami, FRCPCH, MD

ELAPRASE^®▼

REPLAGAL^®

VPRIV^®

You might be interested in

video

Two Decades of Experience from the Fabry Outcome Survey

Dr. Uma Ramaswami, FRCPCH, MD

Adverse Event Reporting:

Forgot Password

Inherited Metabolic Disorders

video

Two Decades of Experience from the Fabry Outcome Survey

Dr. Uma Ramaswami, FRCPCH, MD

Related treatments

ELAPRASE®▼

REPLAGAL®

VPRIV®

You might be interested in

video

Two Decades of Experience from the Fabry Outcome Survey

Dr. Uma Ramaswami, FRCPCH, MD

Login Access

ELAPRASE^®▼

REPLAGAL^®

VPRIV^®